CMOS microelectrode arrays for electrophysiology research and drug discovery
3Brain manufactures CMOS-based microelectrode arrays—biosensors with thousands of integrated electrical sensors—for non-invasive study of neurons, cardiac cells, and muscle tissue. The company's tech stack reveals heavy hardware-software integration: Verilog, SystemVerilog, VHDL, and Synopsys/Cadence for chip design, paired with Python and Linux for data layers. Current hiring focus is skewed toward sales (5 roles) over engineering (4 roles), and projects emphasize direct sales of capital equipment, US market entry, and Japanese expansion—suggesting a scaling phase from R&D into commercial deployment.
3Brain develops and sells CMOS-integrated microelectrode arrays for life-science research. The platform enables researchers to record electrical activity from hundreds or thousands of cells simultaneously in vitro, supporting fundamental neuroscience, disease modeling (Alzheimer's, epilepsy), and compound toxicity screening. The company serves academic labs and pharmaceutical R&D groups. Founded in 2011 and based in Switzerland, 3Brain operates as a hardware-software manufacturer, combining custom sensor fabrication with digital signal processing. Current operations span Switzerland, the US, and Italy, with strategic focus on entering the Japanese market.
Verilog, SystemVerilog, VHDL for hardware design; Synopsys and Cadence for chip design automation; Python and Linux for data processing and control software.
US market expansion, direct sales of capital equipment, scaling manufacturing (mechanical production and assembly), designing next-generation CMOS sensor systems, and expanding into Japan.
Other companies in the same industry, closest in size